SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: erickerickson who wrote (836)1/17/2025 2:39:13 PM
From: galt1 Recommendation

Recommended By
JJINV

   of 1230
 
Please keep SAVA comments to the other boards. Bad Karma.
Assuming you must own some of it.
For that, I'm very sorry for your loss.
IBRX already has a major approval and hopefully more coming.
AS Stockdoc puts it, he only owns, now, stocks that have already gotten final approval on a drug.
In this market, not a bad strategy. Even IBRX share price is suffering, but for other reasons.
Later
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News